Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment

by Christopher Jackson, Jacob Ruzevick, Jillian Phallen, Zineb Belcaid, Michael Lim
Published 2011-01-01

The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy

by Mira A. Patel, Jennifer E. Kim, Jacob Ruzevick, Gordon Li, Michael Lim
Published 2014-09-01

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications

by Jennifer E. Kim, Mira Patel, Jacob Ruzevick, Christopher M. Jackson, Michael Lim
Published 2014-02-01

A Patient with HIV Treated with Ipilimumab and Stereotactic Radiosurgery for Melanoma Metastases to the Brain

by Jacob Ruzevick, Sarah Nicholas, Kristin Redmond, Lawrence Kleinberg, Evan J. Lipson, Michael Lim
Published 2013-01-01

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium

by Eileen S. Kim, Jennifer E. Kim, Mira A. Patel, Antonella Mangraviti, Jacob Ruzevick, Michael Lim
Published 2016-01-01

Erlotinib inhibits growth of a patient-derived chordoma xenograft.

by I-Mei Siu, Jacob Ruzevick, Qi Zhao, Nick Connis, Yuchen Jiao, Chetan Bettegowda, Xuewei Xia, Peter C Burger, Christine L Hann, Gary L Gallia
Published 2013-01-01

Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model.

by Zineb Belcaid, Jillian A Phallen, Jing Zeng, Alfred P See, Dimitrios Mathios, Chelsea Gottschalk, Sarah Nicholas, Meghan Kellett, Jacob Ruzevick, Christopher Jackson, Emilia Albesiano, Nicholas M Durham, Xiaobu Ye, Phuoc T Tran, Betty Tyler, John W Wong, Henry Brem, Drew M Pardoll, Charles G Drake, Michael Lim
Published 2014-01-01